CD70 (Vorsetuzumab Biosimilar) antibody (Biotin)

Catalog No. ABIN7766332

The Human Monoclonal anti-CD70 (Vorsetuzumab Biosimilar) antibody has been validated for ELISA, FACS and CyTox. It is suitable to detect CD70 (Vorsetuzumab Biosimilar) in samples from Human.

Quick Overview for CD70 (Vorsetuzumab Biosimilar) antibody (Biotin) (ABIN7766332)

Target: CD70 (Vorsetuzumab Biosimilar)

Reactivity: Human

Host: Human

Clonality: Monoclonal

Conjugate: This CD70 (Vorsetuzumab Biosimilar) antibody is conjugated to Biotin

Application: ELISA, Flow Cytometry (FACS), Cytotoxicity Test (CyTox)

Product Details anti-CD70 (Vorsetuzumab Biosimilar) Antibody (Biotin)

Purpose: Conjugated Anti-CD70 (vorsetuzumab biosimilar) mAb

Purification: Purified from cell culture supernatant by affinity chromatography

Application Details

Application Notes: working with enzyme-conjugated streptavidin, most applications: 1: 50 - 1: 1,000

Restrictions: For Research Use only

Handling

Buffer: Liquid in PBS, 0.5 % BSA, 40 % Glycerol, 0.02 % Sodium Azide.

Preservative: Sodium azide

Precaution of Use: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Handling Advice: Protect from light!

Storage: 4 °C

Storage Comment: Store at 4°C in dark for 6 months

Target Details for CD70 (Vorsetuzumab Biosimilar)

Target: CD70 (Vorsetuzumab Biosimilar)

Alternative Name: vorsetuzumab biosimilar

Target Type: Biosimilar

Background: CD70, CD27L, CD27LG, TNFSF7